Clinical Trials on Pseudophakic Bullous Keratopathy in Poland
Total 10 results
-
Oregon Health and Science UniversityNational Eye Institute (NEI)Recruiting
-
ReGenTree, LLCRecruitingNeurotrophic KeratopathyUnited States
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
AKARI TherapeuticsWithdrawnBullous PemphigoidUnited States, Germany, Netherlands, Poland
-
argenxActive, not recruitingBullous PemphigoidUnited States, Australia, Bulgaria, China, Croatia, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Serbia, Slovakia, Spain, United Kingdom
-
TWi Biotechnology, Inc.RecruitingGeneralized Epidermolysis Bullosa SimplexUnited States, Taiwan, Australia, Philippines, Austria, Italy, Poland
-
Chugai PharmaceuticalNot yet recruitingAntiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)United States, Japan
-
Shire Regenerative Medicine, Inc.TerminatedEpidermolysis BullosaUnited States, Spain, Austria, Canada, France, Germany, Poland, Portugal
-
Scioderm, Inc.Amicus TherapeuticsTerminatedEpidermolysis BullosaPoland, Spain, Serbia, Netherlands, United States, Austria, Australia, Israel, Germany, France, United Kingdom, Lithuania
-
Scioderm, Inc.Amicus TherapeuticsCompletedEpidermolysis BullosaItaly, Spain, Serbia, United States, Australia, Netherlands, Austria, Germany, Israel, Lithuania, France, United Kingdom, Poland